This inventor holds 2 USPTO granted patents. Top assignee: ETH Zurich. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: Rami Mhanna: Innovator in Sulfated Alginate Hydrogels
Introduction
Rami Mhanna is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of biomedical engineering, particularly in the development of sulfated alginate hydrogels. With a total of two patents to his name, his work focuses on innovative methods for cell culture and therapy.
Latest Patents
Rami Mhanna's latest patents include a method for providing an embedded mammalian cell using sulfated alginate hydrogels. The invention outlines a process that involves providing an alginate sulfate in aqueous solution, reacting it to form a hydrogel, and embedding a precursor cell within this hydrogel. This method yields a sulfated alginate hydrogel embedded cell, which has potential applications in cellular grafts and tissue engineering.
Career Highlights
Rami Mhanna is affiliated with ETH Zurich, a prestigious research institution known for its cutting-edge advancements in science and technology. His work at ETH Zurich has positioned him as a key figure in the development of innovative solutions for cell therapy.
Collaborations
Rami collaborates with esteemed colleagues such as Marcy Zenobi-Wong and Gemma Palazzolo. Their combined expertise enhances the research and development of new biomedical applications.
Conclusion
Rami Mhanna's contributions to the field of sulfated alginate hydrogels represent a significant advancement in biomedical engineering. His innovative methods have the potential to transform cell culture and therapy practices, paving the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
